TY - JOUR
T1 - Functional GPCR expression in eukaryotic LEXSY system
AU - Luginina, Aleksandra
AU - Maslov, Ivan
AU - Khorn, Polina
AU - Volkov, Oleksandr
AU - Khnykin, Andrey
AU - Kuzmichev, Pavel K.
AU - Shevtsov, Mikhail
AU - Belousov, Anatoliy
AU - Kapranov, Ivan
AU - Dashevskii, Dmitrii
AU - Kornilov, Daniil A.
AU - Bestsennaia, Ekaterina
AU - Hofkens, Johan
AU - Hendrix, Jelle
AU - Gensch, Thomas
AU - Cherezov, Vadim
AU - Ivanovich, Valentin
AU - Mishin, Alexey
AU - Borshchevskiy, Valentin
PY - 2023/12/1
Y1 - 2023/12/1
N2 - G protein-coupled receptors (GPCRs) form the largest superfamily of membrane proteins in the human genome, and represent one of the most important classes of drug targets. Their structural studies facilitate rational drug discovery. However, atomic structures of only about 20% of human GPCRs have been solved to date. Recombinant production of GPCRs for structural studies at a large scale is challenging due to their low expression levels and stability. Therefore, in this study, we explored the efficacy of the eukaryotic system LEXSY (Leishmania tarentolae) for GPCR production. We selected the human A2A adenosine receptor (A2AAR), as a model protein, expressed it in LEXSY, purified it, and compared with the same receptor produced in insect cells, which is the most popular expression system for structural studies of GPCRs. The A2AAR purified from both expression systems showed similar purity, stability, ligand-induced conformational changes and structural dynamics, with a remarkably higher protein yield in the case of LEXSY expression. Overall, our results suggest that LEXSY is a promising platform for large-scale production of GPCRs for structural studies.
AB - G protein-coupled receptors (GPCRs) form the largest superfamily of membrane proteins in the human genome, and represent one of the most important classes of drug targets. Their structural studies facilitate rational drug discovery. However, atomic structures of only about 20% of human GPCRs have been solved to date. Recombinant production of GPCRs for structural studies at a large scale is challenging due to their low expression levels and stability. Therefore, in this study, we explored the efficacy of the eukaryotic system LEXSY (Leishmania tarentolae) for GPCR production. We selected the human A2A adenosine receptor (A2AAR), as a model protein, expressed it in LEXSY, purified it, and compared with the same receptor produced in insect cells, which is the most popular expression system for structural studies of GPCRs. The A2AAR purified from both expression systems showed similar purity, stability, ligand-induced conformational changes and structural dynamics, with a remarkably higher protein yield in the case of LEXSY expression. Overall, our results suggest that LEXSY is a promising platform for large-scale production of GPCRs for structural studies.
U2 - 10.1016/j.jmb.2023.168310
DO - 10.1016/j.jmb.2023.168310
M3 - Article
SN - 0022-2836
VL - 435
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 23
M1 - 168310
ER -